Nephrology News

SAN DIEGO — Nearly 75% of kidney transplant recipients at a U.S. hospital who survived at least 1 year did not see a primary care provider in the years following the procedure, according to study data.

Early treatment with mycophenolate mofetil can reduce subsequent risks for severe flares and lupus nephritis in newly diagnosed systemic lupus erythematosus, according to data published in JAMA Network Open.

Prescriptions for GLP-1 receptor agonists and SGLT2 inhibitors for patients with type 1 diabetes rose between 2010 and 2023 despite not being approved for that population, according to a research letter published in JAMA.

The 19th annual Cardiometabolic Health Congress will be held at the Boston Park Plaza and will feature the latest science in the areas of cardio-renal, obesity, diabetes and dyslipidemia, atherosclerosis, thrombosis and more.

Kezar Life Sciences has paused a phase 2b trial of zetomipzomib in active lupus nephritis after reporting four patient deaths, according to a press release from the manufacturer.

Remote BP monitoring and collaborative telehealth visits with a pharmacist improved BP control among patients at rural nephrology clinics and reduced hospitalization, a speaker reported.

In patients with obesity and heart disease, semaglutide 2.4 mg reduced risk for major adverse cardiovascular events regardless of baseline kidney function, according to new data from the SELECT trial.

In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone reduced risk for CV death and worsening HF by 16% compared with placebo, researchers reported at the European Society of Cardiology Congress.

Discontinuation of renin-angiotensin system inhibitor therapy before major noncardiac surgery did not appear to affect postoperative outcomes vs. treatment continuation, a speaker reported.